Genmab — Maj 2017
-
1400 - Godkendt

-
Tak Royal! Jeg synes i er optimister drenge, men lad os se. Måske tager den en lille slut spurt

-
KWC, det er rigtigt, at Nordea har Target price: DKK 1.577 den 11.5. Jeg kan se, af samme opdatering, at de også har en Fair value: DKK 1.463. Jeg synes ellers at de plejer kun at opererer med værdien i dag. Er det ikke noget nyt og hvor mange måneder er der mon til forskel på de to kursmål?
-
Jeg kan se Novod skrev "We still believe in a likely guidance upgrade later in the year and now see focus turning back onto strong pipeline news over the next 12 months, starting with JnJ's CMD on 17 May and ASCO by late May. We maintain our Buy rating and raise our DCF-based target price to DKK 1,577 (1,570).
-
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Company Announcement Copenhagen, Denmark; May 16, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 43,252 shares as a...
GlobeNewswire News Room (globenewswire.com)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind